✦ LIBER ✦

6079 Overall survival of patients with KRAS wild-type tumours treated with FOLFOX4± cetuximab as 1st-line treatment for metastatic colorectal cancer: The OPUS study

✍ Scribed by Bokemeyer, C.; Bondarenko, I.; Hartmann, J.T.; DeBraud, F.; Schuch, G.; Zubel, A.; Celik, I.; Koralewski, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6078 Cetuximab plus FOLFIRI in 1st-line

✍ Lang, I.; Köhne, C.H.; Folprecht, G.; Nowacki, M.P.; Cascinu, S.; Shchepotin, I. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

PCN70 Cost-Effectiveness of Cetuximab an

✍ Samyshkin, Y.; Hertel, N.; Griebsch, I. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

3617 POSTER Cost-Effectiveness of Cetuxi

✍ Samyshkin, Y.; Hertel, N.; Griebsch, I. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

6077 A meta-analysis of the CRYSTAL and

✍ Van Cutsem, E.; Rougier, P.; Köhne, C.; Stroh, C.; Schlichting, M.; Bokemeyer, C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

10LBA Randomized phase 3 study of panitu

✍ J. Douillard; S. Siena; J. Cassidy; J. Tabernero; R. Burkes; M.E. Barugel; Y. Hu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

FOLFIRI plus cetuximab versus FOLFIRI pl

✍ Stintzing, S.; Fischer von Weikersthal, L.; Decker, T.; Vehling-Kaiser, U.; Jage 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 225 KB